富血小板血漿 (PRP) 市場：按類型、來源、應用、地區 - 規模、份額、展望、機會分析，2022-2030 年

富血小板血漿 (PRP) 是圓形血液中血小板濃度高於正常值的血漿部分。 血小板含有有助於癒合、組織再生和出血的生物蛋白質。 血小板由三種蛋白質組成，即纖維蛋白、纖連蛋白和玻連蛋白，它們充當細胞粘附分子。 PRP 療法可以改善與關節和外傷相關的傷口癒合。 它可以改善其他整容手術，治療男性型脫髮，促進頭髮移植生長。

為了促進受傷的肌腱、韌帶、肌肉和關節的修復，富血小板血漿 (PRP) 療法包括注射患者自身的濃縮血小板。 PRP 注射通過增強每個患者的自然癒合過程來治療肌肉骨骼問題。 一到幾管您自己的血液用於準備 PRP 注射。 這是通過離心血液以濃縮血小板來完成的。 然後將這些活化的血小板注射到受損或患病的身體組織中。 這會釋放生長因子並刺激和增強體內修復細胞的產生。

市場動態

富血小板血漿在面部年輕化和毛髮生長整形手術中作用的演變預計將在預測期內推動全球富血小板血漿市場。 例如，在 2021 年 1 月 1 日發表於國家醫學圖書館的一篇論文中，一種強大的、無偏差的測量技術顯示了皮膚再生、毛髮生長、傷口癒合和脂肪移植收穫的成功治療結果。據說有證明 使用富含血小板的血漿作為脫髮和皮膚再生的獨特療法在治療上是有益的。

這項研究的主要特點

• 本報告對全球富血小板血漿市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%) 增長情況。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，對全球富血小板血漿市場的主要參與者進行概況分析。
• 本研究涵蓋的主要公司包括 Arthrex, Inc.、Stryker Corporation、Johnson and Johnsons Ltd.、Zimmer Biomet Holdings Inc.、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab S.A.、CollPlant、Generex Biotechnology Corporation, Estar Technologies Ltd., Dr. PRP America, Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp.
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 全球富血小板血漿市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過在全球富血小板血漿市場分析中使用的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第2章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按類型分類
  • 市場概況：按產地分類
  • 市場概況，按應用分類
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 技術概述
• 監管場景
• 管道分析
• 害蟲分析

第 4 章全球富血小板血漿 (PRP) 市場-冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球富血小板血漿 (PRP) 市場，按類型，2017-2030

• 純 PRP
• LR-PRP
• 純 PRF
• LR-PRF

第 6 章。全球富血小板血漿 (PRP) 市場，按來源，2017-2030

• 自體血漿
• 同種異體
• 同類產品

第 7 章全球富血小板血漿 (PRP) 市場的應用，2017-2030

• 神經外科
• 整容手術
• 骨科
• 普通外科
• 其他

第 8 章全球富血小板血漿 (PRP) 市場，按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Arthrex, Inc.
• Stryker Corporation
• Johnson and Johnsons Ltd.
• Zimmer Biomet Holdings Inc.
• Terumo Corporation
• Glofinn Oy
• Medira Ltd.
• Regen Lab S.A
• CollPlant
• Generex Biotechnology Corporation
• Estar Technologies Ltd
• Dr. PRP America
• Cesca Therapeutics, Inc.
• Arteriocyte Medical Systems
• Harvest Technologies Corp

第 10 章

• 調查方法
• 關於出版商

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. PRP therapy can improve joint and trauma-related wound healing. The surgery can improve other aesthetic surgeries, treat male pattern baldness, and encourage the growth of hair transplants.

To promote the repair of injured tendons, ligaments, muscles, and joints, platelet-rich plasma (PRP) therapy involves injections of a patient's own concentrated platelets. PRP injections work to treat musculoskeletal issues by enhancing each patient's natural healing process. One to several tubes of your own blood are used to prepare PRP injections, which is done by centrifuging the blood to concentrate the platelets. The damaged or ill body tissue is subsequently given an injection of these activated platelets. This causes the release of growth factors, which promote and boost your body's production of reparative cells.

Market Dynamics

Evolving role of platelet rich plasma in plastic surgeries for facial rejuvenation and hair restoration is expected to drive the global platelet rich plasma market over the forecast period. For instance, on January 1, 2021, an article published in national library of medicine stated that there is a strong proof using unbiased measurement techniques that shows successful treatment results for skin rejuvenation, hair development, wound healing, and fat graft take. There is a therapeutic benefit to using plasma rich in platelets as a unique treatment method for alopecia and skin rejuvenation.

Key features of the study:

• This report provides in-depth analysis of the global platelet rich plasma market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Dr. PRP America, Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market

Detailed Segmentation:

• Global Platelet Rich Plasma Market, By Type:
  • Pure PRP
  • Leukocyte rich PRP
  • Pure PRF
  • Leukocyte rich PRF
• Global Platelet Rich Plasma Market, By Origin:
  • Autologous
  • Allogenic
  • Homologues
• Global Platelet Rich Plasma Market, By Application:
  • Neurosurgery
  • Cosmetic Surgery
  • Orthopedic Surgery
  • General Surgery
  • Others
• Global Platelet Rich Plasma Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Arthrex, Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Stryker Corporation
  • Johnson and Johnsons Ltd.
  • Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Glofinn Oy
  • Medira Ltd.
  • Regen Lab S.A.
  • CollPlant
  • Generex Biotechnology Corporation
  • Estar Technologies Ltd.
  • PRP America
  • Cesca Therapeutics, Inc.
  • Arteriocyte Medical Systems
  • Harvest Technologies Corp.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Origin
  • Market Snapshot, By Application
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pipeline Analysis
• PEST Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Platelet Rich Plasma Market, By Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pure PRP
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Leukocyte rich PRP
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Pure PRF
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Leukocyte rich PRF
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Platelet Rich Plasma Market, By Origin, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Autologous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Allogenic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Homologues
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Platelet Rich Plasma Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Neurosurgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cosmetic Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Orthopedic Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• General Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Platelet Rich Plasma Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Arthrex, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Stryker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson and Johnsons Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zimmer Biomet Holdings Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Glofinn Oy
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medira Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regen Lab S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CollPlant
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Generex Biotechnology Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Estar Technologies Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Dr. PRP America
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cesca Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Arteriocyte Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Harvest Technologies Corp
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us